These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34814035)

  • 1. Effectiveness of lacosamide in children and young adults previously treated with other sodium channel blockers.
    Suzuki T; Natsume J; Kumai S; Maki Y; Yamamoto H; Numoto S; Narahara S; Kubota T; Tsuji T; Kato T; Yamada K; Maruyama K; Okumura A; Takahashi Y; Kidokoro H
    Epilepsy Behav; 2021 Dec; 125():108397. PubMed ID: 34814035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort.
    McGinnis E; Kessler SK
    Epilepsia; 2016 Sep; 57(9):1416-25. PubMed ID: 27430392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from traditional sodium channel blockers to lacosamide in patients with epilepsy.
    Kim DW; Kim HK; Bae EK
    Seizure; 2019 Feb; 65():172-175. PubMed ID: 30721874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
    Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
    Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
    Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
    Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide in patients with intellectual disability and refractory epilepsy.
    Kleist A; Kerling F; Hamer H; Winterholler M
    Acta Neurol Belg; 2019 Sep; 119(3):423-430. PubMed ID: 30840220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
    Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
    Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patients.
    Böttcher S; Lutz MT; Mayer T
    Epilepsia; 2017 Oct; 58(10):1749-1754. PubMed ID: 28804872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of the dose and blood concentration of lacosamide in Japanese pediatric patients with epilepsy: A cohort study.
    Ishikawa N; Eguchi Y; Izumo H; Tateishi Y; Tani H; Kobayashi Y; Okada S
    Epilepsy Behav; 2022 Apr; 129():108614. PubMed ID: 35203014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium channel blockers are effective for benign infantile epilepsy.
    Numoto S; Kurahashi H; Takagi M; Azuma Y; Iwayama H; Okumura A
    Seizure; 2021 Nov; 92():207-210. PubMed ID: 34592700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of lacosamide in children: experience of a tertiary medical care center in Brazil.
    Romão TT; Angelim AIM; Prado HJPD; Goes FV; Pires MEP; Fontana RDS; Pires LC; Fernandes AR; D'Andrea-Meira I
    Arq Neuropsiquiatr; 2022 Nov; 80(11):1090-1096. PubMed ID: 36577407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
    Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
    CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: A prospective study evaluating efficacy, tolerability, and behavior.
    Zhou R; Qu R; Liu M; Huang DP; Zhou JY; Chen Y; Chen XQ
    Epilepsy Behav; 2023 Sep; 146():109353. PubMed ID: 37481960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center.
    Kurth C; Kockelmann E; Steinhoff BJ
    Seizure; 2017 Feb; 45():47-51. PubMed ID: 27915111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
    Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
    Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational polytherapy with lacosamide in clinical practice: results of a Spanish cohort analysis RELACOVA.
    Villanueva V; López-Gomáriz E; López-Trigo J; Palau J; García M; Villarroya T; Bonet M; Santafé C
    Epilepsy Behav; 2012 Mar; 23(3):298-304. PubMed ID: 22370116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
    Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
    Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.